Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study
COVID-19 관련 급성 호흡기 병원 증후군에서 정맥 내 면역 글로불린 요법의 임상 결과 : 후 향적 코호트 연구
Research
[키워드] 95% CI
Acute kidney injury
acute respiratory distress
acute respiratory distress syndrome
addition
adjust
AKI
Analysis
ARDS
clinical
Cohort
conducted
confounders
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patient
Electronic health record
Electronic health records
General Hospital
groups
ICU
ICU mortality
ICUs
Immunoglobulin
immunoglobulin therapy
immunomodulatory therapy
incidence
intensive care unit
intensive care units
Intravenous immunoglobulin
Invasive mechanical ventilation
IVIG
mechanical ventilation
mechanically ventilated
mechanically ventilated patient
mechanically ventilated patients
Mortality
observation
outcome
Patient
Primary outcome
Propensity score
propensity score matching
randomized clinical trial
receiving
respiratory distress
Respiratory distress syndrome
Result
Retrospective analysis
retrospective cohort study
routine care
secondary
Secondary outcomes
significantly higher
statistically significant difference
study population
supplementary material
survival
survival analysis
syndrome
systemic inflammation
therapy
two group
two groups
ventilator-free day
Ventilator-free days
was used
with COVID-19
[DOI] 10.1186/s12890-021-01717-x PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s12890-021-01717-x PMC 바로가기 [Article Type] Research